Symptoms of a phenindamine overdose include extreme sleepiness, confusion, weakness, ringing in the ears, blurred vision, large pupils, dry mouth, flushing, fever, shaking, insomnia, hallucinations, and possibly seizures.
Phenindamine is an antihistamine. Phenindamine blocks the effects of the naturally occurring chemical histamine in your body. Antihistamines such as phenindamine appear to compete with histamine for histamine H1- receptor sites on effector cells. The antihistamines antagonize those pharmacological effects of histamine which are mediated through activation of H1- receptor sites and thereby reduce the intensity of allergic reactions and tissue injury response involving histamine release. It is used to treat sneezing, runny nose, itching, watery eyes, hives, rashes, itching, and other symptoms of allergies and the common cold.
Symptoms of a phenindamine overdose include extreme sleepiness, confusion, weakness, ringing in the ears, blurred vision, large pupils, dry mouth, flushing, fever, shaking, insomnia, hallucinations, and possibly seizures.
Fitur visualisasi ini dikembangkan menggunakan pendekatan Graph Theory untuk memetakan hubungan polifarmasi dan molekuler. Entitas (Obat, Target, Gen) direpresentasikan sebagai Simpul (Nodes), sedangkan hubungan biologisnya sebagai Sisi (Edges).
drugbank-id dan name pada skema XML DrugBank.targets/target yang memuat polipeptida sasaran.gene-name dan varian snp-effects.Tata letak grafik menggunakan algoritma Force-Directed Graph (Barnes-Hut). Model fisika ini menerapkan gaya tolak-menolak antar simpul (Gravitasi: -3000) agar tidak tumpang tindih, serta gaya pegas (Spring: 0.04) pada garis penghubung untuk fleksibilitas interaksi.
| Benzylpenicilloyl polylysine | Phenindamine may decrease effectiveness of Benzylpenicilloyl polylysine as a diagnostic agent. |
| Betahistine | The therapeutic efficacy of Betahistine can be decreased when used in combination with Phenindamine. |
| Hyaluronidase (ovine) | The therapeutic efficacy of Hyaluronidase (ovine) can be decreased when used in combination with Phenindamine. |
| Hyaluronidase (human recombinant) | The therapeutic efficacy of Hyaluronidase (human recombinant) can be decreased when used in combination with Phenindamine. |
| Hyaluronidase | The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Phenindamine. |
| Amphetamine | Amphetamine may decrease the sedative activities of Phenindamine. |
| Phentermine | Phentermine may decrease the sedative activities of Phenindamine. |
| Pseudoephedrine | Pseudoephedrine may decrease the sedative activities of Phenindamine. |
| Benzphetamine | Benzphetamine may decrease the sedative activities of Phenindamine. |
| Diethylpropion | Diethylpropion may decrease the sedative activities of Phenindamine. |
| Lisdexamfetamine | Lisdexamfetamine may decrease the sedative activities of Phenindamine. |
| Mephentermine | Mephentermine may decrease the sedative activities of Phenindamine. |
| MMDA | MMDA may decrease the sedative activities of Phenindamine. |
| Midomafetamine | Midomafetamine may decrease the sedative activities of Phenindamine. |
| 2,5-Dimethoxy-4-ethylamphetamine | 2,5-Dimethoxy-4-ethylamphetamine may decrease the sedative activities of Phenindamine. |
| 4-Bromo-2,5-dimethoxyamphetamine | 4-Bromo-2,5-dimethoxyamphetamine may decrease the sedative activities of Phenindamine. |
| Tenamfetamine | Tenamfetamine may decrease the sedative activities of Phenindamine. |
| Chlorphentermine | Chlorphentermine may decrease the sedative activities of Phenindamine. |
| Methylenedioxyethamphetamine | Methylenedioxyethamphetamine may decrease the sedative activities of Phenindamine. |
| Dextroamphetamine | Dextroamphetamine may decrease the sedative activities of Phenindamine. |
| Metamfetamine | Metamfetamine may decrease the sedative activities of Phenindamine. |
| Iofetamine I-123 | Iofetamine I-123 may decrease the sedative activities of Phenindamine. |
| Ritobegron | Ritobegron may decrease the sedative activities of Phenindamine. |
| Mephedrone | Mephedrone may decrease the sedative activities of Phenindamine. |
| Methoxyphenamine | Methoxyphenamine may decrease the sedative activities of Phenindamine. |
| Gepefrine | Gepefrine may decrease the sedative activities of Phenindamine. |
| 2,5-Dimethoxy-4-ethylthioamphetamine | 2,5-Dimethoxy-4-ethylthioamphetamine may decrease the sedative activities of Phenindamine. |
| Phendimetrazine | Phendimetrazine may decrease the sedative activities of Phenindamine. |
| Pitolisant | The therapeutic efficacy of Pitolisant can be decreased when used in combination with Phenindamine. |
| Norepinephrine | The therapeutic efficacy of Norepinephrine can be increased when used in combination with Phenindamine. |
| Epinephrine | The therapeutic efficacy of Epinephrine can be increased when used in combination with Phenindamine. |
| Droxidopa | The therapeutic efficacy of Droxidopa can be increased when used in combination with Phenindamine. |
| Levonordefrin | The therapeutic efficacy of Levonordefrin can be increased when used in combination with Phenindamine. |
| Protokylol | The therapeutic efficacy of Protokylol can be increased when used in combination with Phenindamine. |
| Racepinephrine | The therapeutic efficacy of Racepinephrine can be increased when used in combination with Phenindamine. |
| Theodrenaline | The therapeutic efficacy of Theodrenaline can be increased when used in combination with Phenindamine. |
| Deoxyepinephrine | The therapeutic efficacy of Deoxyepinephrine can be increased when used in combination with Phenindamine. |
| Ephedrine | The therapeutic efficacy of Ephedrine can be increased when used in combination with Phenindamine. |
| Hyoscyamine | Phenindamine may increase the anticholinergic activities of Hyoscyamine. |